ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Abstracts tagged "anti-TNF therapy and methotrexate (MTX)"

  • Abstract Number: 1823 • ACR/ARHP Annual Meeting 2017

    Methotrexate Requires High Serum BAFF Levels to Prevent Immunization Against TNF-α Inhibitors

    Samuel Bitoun1, Pierre Dönnes2, Aline Doublet3, Kimberly Florence4, Agnes Hincelin-Mery5, Gaetane Nocturne6, Mattieu Allez7, N Ruperto8, Marc Pallardy9 and Xavier Mariette10, 1INSERM U1184, IMVA, Paris Sud University,LabEx LERMIT, Le Kremlin Bicëtre, France, 2SciCross AB, Skövde, Sweden, 3Department of Rheumatology, Kremlin-Bicêtre hospital INSERM U1184, Le Kremlin Bicêtre, France, 4Immunogenicity and Clinical Immunology, GlaxoSmithKline, King of Prussia, PA, 5Sanofi, Chilly-Mazarin, France, 6INSERM U1184, IMVA, Paris Sud University,LabEx LERMIT, Le Kremlin Bicêtre, France, 7Department of Gastroenterology, Hopital Saint-Louis, APHP, Paris, France, 8PRINTO Coordinating Centre, Genoa, Italy, 9Inflammation, Chimiokines et Immunopathologie, INSERM UMR 996, Faculté de Pharmacie, Chatenay Mallabry, France, 10Université Paris Sud, Paris, France

    Background/Purpose: Immunization against TNF Inhibitors (TNFi) is observed in 30-50% of patients with inflammatory rheumatic diseases. With most TNFi, anti-drug antibodies (ADA) lead to rapid…
  • Abstract Number: 142 • ACR/ARHP Annual Meeting 2015

    Exploration of General Practioners’ Difficulties with Methotrexate and Anti-TNF Therapies in Routine Practice

    Elise Berthet1, Virginie Moiroud2, Marion De Rosa2, Martin Soubrier3 and Sylvain Mathieu4, 1Rheumatology, CHU Gabriel Montpied, Clermont-Ferrand, France, 2Médecine Générale, CHU Gabriel Montpied, Clermont-Ferrand, France, 3Rheumatology department CHU Clermont-Ferrand, Clermont-Ferrand, France, 4Rheumatology Department, CHU clermont-Ferrand, Clermont-Ferrand, France

    Background/Purpose: Chronic inflammatory arthritis affects around 1% of the general population. Disease-modifying drugs like methotrexate (MTX) and in second-line anti tumor necrosis factor (anti-TNF) therapy…

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology